Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

A prospective multicenter evaluation of direct molecular detection of blood stream infection from a clinical perspective

Authors: A. E. Nieman, P. H. M. Savelkoul, A. Beishuizen, B. Henrich, B. Lamik, C. R. MacKenzie, D. Kindgen-Milles, A. Helmers, C. Diaz, S. G. Sakka, R. P. Schade

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Rapid diagnosis and appropriate antimicrobial therapy are of major importance to decrease morbidity and mortality in patients with blood stream infections (BSI). Blood culture, the current gold standard for detecting bacteria in blood, requires at least 24–48 hours and has limited sensitivity if obtained during antibiotic treatment of the patient. The aim of this prospective multicenter study was to clinically evaluate the application of a commercial universal 16S/18S rDNA PCR, SepsiTest™ (PCR-ST), directly on whole blood.

Methods

In total 236 samples from 166 patients with suspected sepsis were included in the study. PCR-ST results were compared to blood culture, the current gold standard for detecting BSI. Because blood cultures can give false-negative results, we performed an additional analysis to interpret the likelihood of bloodstream infection by using an evaluation based on clinical diagnosis, other diagnostic tests and laboratory parameters.

Results

Clinical interpretation of results defined the detected organism to be contaminants in 22 of 43 positive blood cultures (51.2 %) and 21 of 47 positive PCR-ST results (44.7 %). Excluding these contaminants resulted in an overall sensitivity and specificity of the PCR-ST of 66.7 and 94.4 % respectively. Of the 36 clinically relevant samples, 11 BSI were detected with both techniques, 15 BSI were detected with PCR-ST only and 10 with blood culture only. Therefore, in this study, SepsiTest™ detected an additional 71 % BSI compared to blood culture alone.

Conclusions

More clinically relevant BSI were diagnosed by molecular detection, which might influence patient treatment. An improved SepsiTest™ assay suited for routine use can have additional value to blood culture in diagnosing bacteremia in septic patients.
Literature
1.
Machado FR, Mazza BF. Improving mortality in sepsis: analysis of clinical trials. Shock. 2010;34 Suppl 1:54–8.CrossRefPubMed
2.
Mann E a, Baun MM, Meininger JC, Wade CE. Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature. Shock. 2012;37:4–16.CrossRefPubMed
3.
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the united states from 1979 through 2000. N Engl J Med. 2003;348:1546–54.CrossRefPubMed
4.
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the united states: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.CrossRefPubMed
5.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–74.CrossRef
6.
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.CrossRefPubMed
7.
Flaherty SK, Weber RL, Chase M, Dugas AF, Graver AM, Salciccioli JD, Cocchi MN, Donnino MW: Septic Shock and Adequacy of Early Empiric Antibiotics in the Emergency Department. J Emerg Med. 2014;47:601-7.
8.
Macarthur RD, Miller M, Albertson T, Panacek E, Johnson D, Teoh L, et al. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis. 2004;38:284–8.CrossRefPubMed
9.
Miano TA, Powell E, Schweickert WD, Morgan S, Binkley S, Sarani B. Effect of an antibiotic algorithm on the adequacy of empiric antibiotic therapy given by a medical emergency team. J Crit Care. 2012;27:45–50.CrossRefPubMed
10.
Sligl WI, Dragan T, Smith SW: Nosocomial Gram-Negative Bacteremia in Intensive Care: Epidemiology, Antimicrobial Susceptibilities and Outcomes. Int J Infect Dis. 2015;37:129-34.
11.
Beutz M, Sherman G, Mayfield J, Fraser VJ, Kollef MH. Clinical utility of blood cultures drawn from central vein catheters and peripheral venipuncture in critically ill medical patients. Chest. 2003;123:854–61.CrossRefPubMed
12.
Glerant JC, Hellmuth D, Schmit JL, Ducroix JP, Jounieaux V. Utility of blood cultures in community-acquired pneumonia requiring hospitalization: influence of antibiotic treatment before admission. Respir Med. 1999;93:208–12.CrossRefPubMed
13.
McKenzie R, Reimer LG. Effect of antimicrobials on blood cultures in endocarditis. Diagn Microbiol Infect Dis. 1987;8:165–72.CrossRefPubMed
14.
Peters RPH, Van Agtmael M a, Gierveld S, Danner S a, Groeneveld a BJ, Vandenbroucke-Grauls CMJE, et al. Quantitative detection of staphylococcus aureus and enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J Clin Microbiol. 2007;45:3641–6.CrossRefPubMedPubMedCentral
15.
Ruiz-Giardín JM, Martin-Díaz RM, Jaqueti-Aroca J, Garcia-Arata I, San Martín-López JV, Sáiz-Sánchez Buitrago M. Diagnosis of bacteraemia and growth times. Int J Infect Dis. 2015;41:6–10.CrossRefPubMed
16.
17.
Hansen WLJ, Bruggeman CA, Wolffs PFG. Evaluation of new preanalysis sample treatment tools and DNA isolation protocols to improve bacterial pathogen detection in whole blood. J Clin Microbiol. 2009;47:2629–31.CrossRefPubMedPubMedCentral
18.
Hedman J, Rådström P: Overcoming Inhibition in Real-Time Diagnostic PCR. In PCR Detection of Microbial Pathogens: Second Edition, Methods in Molecular Biology. Volume 943; 2013:17–49.
19.
Morata P, Queipo-Ortuño MI, de Dios Colmenero J. Strategy for optimizing DNA amplification in a peripheral blood PCR assay used for diagnosis of human brucellosis. J Clin Microbiol. 1998;36:2443–6.PubMedPubMedCentral
20.
Smith K, Diggle M a, Clarke SC. Comparison of commercial DNA extraction kits for extraction of bacterial genomic DNA from whole-blood samples. J Clin Microbiol. 2003;41:2440–3.CrossRefPubMedPubMedCentral
21.
22.
Grif K, Fille M, Würzner R, Weiss G, Lorenz I, Gruber G, et al. Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsis. Wien Klin Wochenschr. 2012;124:266–70.CrossRefPubMed
23.
Josefson P, Strålin K, Ohlin a, Ennefors T, Dragsten B, Andersson L, et al. Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infections. Eur J Clin Microbiol Infect Dis. 2011;30:1127–34.CrossRefPubMed
24.
Bravo D, Blanquer J, Tormo M, Aguilar G, Borrás R, Solano C, et al. Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients. Int J Infect Dis. 2011;15:326–31.CrossRef
25.
Tafelski S, Nachtigall I, Adam T, Bereswill S, Faust J, Tamarkin A, et al. Randomized controlled clinical trial evaluating multiplex polymerase chain reaction for pathogen identification and therapy adaptation in critical care patients with pulmonary or abdominal sepsis. J Int Med Res. 2015;43:364–77.CrossRefPubMed
26.
Morgenthaler NG, Kostrzewa M. Rapid identification of pathogens in positive blood culture of patients with sepsis: review and meta-analysis of the performance of the sepsityper Kit. Int J Microbiol. 2015;2015:1–10.CrossRef
27.
Bacconi A, Richmond GS, Baroldi M a, Laffler TG, Blyn LB, Carolan HE, et al. Improved sensitivity for molecular detection of bacterial and Candida infections in blood. J Clin Microbiol. 2014;52:3164–74.CrossRefPubMedPubMedCentral
28.
Jordana-Lluch E, Giménez M, Quesada MD, Rivaya B, Marcó C, Domínguez MJ, et al. Evaluation of the broad-range PCR/ESI-MS technology in blood specimens for the molecular diagnosis of bloodstream infections. PLoS One. 2015;10, e0140865.CrossRefPubMedPubMedCentral
29.
Wellinghausen N, Kochem A-J, Disqué C, Mühl H, Gebert S, Winter J, et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol. 2009;47:2759–65.CrossRefPubMedPubMedCentral
30.
Pasqualini L, Mencacci A, Leli C, Montagna P, Cardaccia A, Cenci E, et al. Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol. 2012;50:1285–8.CrossRefPubMedPubMedCentral
31.
Cockerill FR, Wilson JW, Vetter EA, Goodman KM, Torgerson CA, Harmsen WS, et al. Optimal testing parameters for blood cultures. Clin Infect Dis. 2004;38:1724–30.CrossRefPubMed
32.
Lee A, Mirrett S, Reller LB, Weinstein MP: Detection of Bloodstream Infections in Adults : How Many Blood Cultures Are Needed? J Clin Microbiol. 2007;45:3546–8.
33.
34.
Tomás I, Diz P, Tobías A, Scully C, Donos N. Periodontal health status and bacteraemia from daily oral activities: systematic review/meta-analysis. J Clin Periodontol. 2012;39:213–28.CrossRefPubMed
35.
Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol. 2006;33:401–7.CrossRefPubMed
36.
Wilson W, Taubert K a, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American heart association: a guideline from the American heart association rheumatic fever, endocarditis, and Kawasaki disease committee, council on cardiovascular disease in the young, and the Co. Circulation. 2007;116:1736–54.CrossRefPubMed
37.
Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis: recommendations by the American heart association. Clin Infect Dis. 1997;25:1448–58.CrossRefPubMed
Metadata
Title
A prospective multicenter evaluation of direct molecular detection of blood stream infection from a clinical perspective
Authors
A. E. Nieman
P. H. M. Savelkoul
A. Beishuizen
B. Henrich
B. Lamik
C. R. MacKenzie
D. Kindgen-Milles
A. Helmers
C. Diaz
S. G. Sakka
R. P. Schade
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1646-4

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue

Erratum

Erratum to: Risk of cardiovascular events among patients with HIV treated with atazanavircontaining regimens: a retrospective cohort study

Research article

N-terminal pro-brain natriuretic peptide levels associated with severe hand, foot and mouth disease

Research article

The prevalence of human papillomavirus infections and associated risk factors in men-who-have-sex-with-men in Cape Town, South Africa

Research article

Vancomycin in infusion during vitrectomy in surgical treatment of acute postoperative and posttraumatic endophthalmitis

Research article

Impact of changing from staining to culture techniques on detection rates of Campylobacter spp. in routine stool samples in Chile

Research article

Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits